CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model

Transplantation

Volumn 59, Issue 1, 1995, Pages 69-78

  Jakic Razumovic, Jasminka ^a   Sale, George E ^a,b   Beauchamp, Mary D ^a   Storb, Rainer ^a,b   Sandmaier, Brenda M ^a,b  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOG; GRAFT VERSUS HOST REACTION; KERATINOCYTE; MIXED LEUKOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; SKIN FIBROBLAST; T LYMPHOCYTE ACTIVATION;

ANIMAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; DOGS; GRAFT REJECTION; HLA-D ANTIGENS; INTERFERON TYPE II; KERATINOCYTES; NECROSIS; SKIN; SKIN TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE CULTURE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR;

EID: 0028851048     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199501150-00013     Document Type: Article

References (64)

1. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964.
2. Ferrara JLM. Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation. Bone Marrow Transplant 1992; 10 (suppl 1): 10.
3. Symington FW, Storb R. Mechanisms of tissue damage in hu man acute graft-versus-host disease. J Immunol Immunophar-macol 1989; 9: 214.
4. Lampert IA, Janossy G, Suitters AJ, et al. Immunological analy sis of the skin in graft versus host disease. Clin Exp Immunol 1982; 50: 123.
5. Sloane JP, Thomas JA, Imrie SF, Easton DF, Powles RL. Mor phological and immunohistological changes in the skin in allogeneic bone marrow recipients. J Clin Pathol 1984; 37: 919.
6. Korngold R, Sprent J. T cell subsets and graft-versus-host dis ease. Transplantation 1987; 44: 335.
7. Norton J, al-Saffar N, Sloane JP. An immunohistological study of gamma/delta lymphocytes in human cutaneous graft-versus-host disease. Bone Marrow Transplant 1991; 7: 205.
8. Fujii H, Ohashi M, Nagura H. Immunohistochemical analysis of oral lichen-planus-like eruption in graft-versus-host disease after allogeneic bone marrow transplantation. Am J Clin Pathol 1988; 89: 177.
9. Janossy G, Montano L, Selby WS, et al. T cell subset abnormali ties in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J Clin Immunol 1982; 2: 42S.
10. Guyotat D, Mauduit G, Chouvet B, et al. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation 1986; 41: 340.
11. Lever R, Turbitt M, Mackie R, et al. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants. Br J Dermatol 1986; 114: 161.
12. Korngold R, Sprent J. Lethal GVHD across minor histocompat ibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev 1983; 71: 5.
13. Woodruff JM, Butcher WI, Hellerstein LJ. Early secondary dis ease in the rhesus monkey. II. Electron microscopy of changes in the mucous membranes and external epithelia as demonstrated in the tongue and lip. Lab Invest 1972; 27: 85.
14. Gallucci BB, Sale GE, McDonald GB, Epstein R, Sliulman HM, Thomas ED. The fine structure of human rectal epithelium in acute graft-versus-host disease. Am J Surg Pathol 1982; 6: 293.
15. Sale GE, Gallucci BB, Schubert MM, Sullivan KM, Thomas ED. Direct ultrastructural evidence of target-directed polarization by cytotoxic lymphocytes in lesions of human graft-vs.-host disease. Arch Pathol Lab Med 1987; 111: 333.
16. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211: 1052.
17. Asselineau D, Prunieras M. Reconstruction of "simplified" skin: control of fabrication. Br J Dermatol 1984; 27: 219.
18. Kopan R, Traska G, Fuchs E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keríitinization. J Cell Biol 1987; 105: 427.
19. Blanton RA, Perez-Reyes N, Merrick DT, McDougall JK. Epi thelial cells immortalized by human Papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol 1991; 138: 673.
20. Merrick DT, Blanton RA, Gown AM, McDougall JK. Altered expression of proliferation and differentiation markers in human Papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol 1992; 140: 167.
21. Jakic-Razumovic J, Storb R, Sandmaier BM, Sale GE. Organo typic skin culture model in dogs: a model for transplantation immunopathology in canine systems. Transplantation 1994; 56: 285.
22. Shalaby MR, Fendly B, Sheehan K, Schreiber RD, Ammann AJ. Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation 1989; 47: 1057.
23. Symington FW, Pepe MS, Chen AB, Deliganis A. Serum tumor necrosis alpha associated with acute graft-versus-host disease in humans. Transplantation 1990; 50: 518.
24. Piguet P-F, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 1987; 166: 1280.
25. Dickinson AM, Sviland L, Carey P, et al. Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant 1988; 3: 323.
26. Dickinson AM, Sviland L, Dunn J, Carey P, Proctor SJ. Demon stration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model. Bone Marrow Transplant 1991; 7: 209.
27. Kaye VN, Neumann PM, Kersey J, et al. Identity of immune cells in graft-versus-host disease of the skin. Analysis using monoclonal antibodies by indirect immunofluorescence. Am J Pathol 1984; 116: 436.
28. Atkinson K, Munro V, Vasak E, Biggs J. Mononuclear cell sub populations in the skin defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. Br J Dermatol 1986; 114: 145.
29. Sviland L, Pearson AD, Green MA, et al. Immunopathology of early graft-versus-host disease-a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients. Transplantation 1991; 52: 1029.
30. Flowers MED, Stockschlaeder MAR, Schuening FG, et al. Long term transplantation of canine keratinocytes made resistant to G418 though retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1990; 87: 2349.
31. Raff RF, Storb R, Ladiges WC, Deeg HJ. Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes. Transplantation 1985; 40: 323.
32. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Sevems E. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992; 40: 75.
33. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984; 68: 167.
34. Wang AM, Creasey AA, Ladner MB, et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985; 228: 149.
35. Hogan MM, Vogel SN. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J Immunol 1988; 141: 4196.
36. Fuller L, Fernandez J, Zheng S, et al. Immunochemical and biochemical characterization of purified canine interferon-gamma. Production of a monoclonal antibody, affinity purification, and its effect on mixed lymphocyte culture and mixed lymphocyte kidney culture reactions. Transplantation 1992; 53: 195.
37. Polak JM, van Noorden S. Immunocytochemistry. Modem meth ods and applications, 2nd ed. Bristol, UK: Wright, 1986.
38. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770.
39. Korngold B, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978; 148: 1687.
40. Ghayur T, Seemayer TA, Lapp WS. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Transplantation 1987; 44: 254.
41. Ghayur T, Seemayer TA, Kongshavn PA, Gartner JG, Lapp WS. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease. Transplantation 1987; 44: 261.
42. Clancy J Jr, Mauser L, Chapman AL. Level and temporal pat tern of naturally cytolytic cells during acute graft-versus-host disease (GVHD) in the rat. Cell Immunol 1983; 79: 1.
43. Sale GE, Lerner KG, Barker EA, et al. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 1977; 89: 621.
44. Sale GE, Shulman HM. The pathology of bone marrow trans plantation. New York: Masson Publishing, 1984.
45. Hamilton BL. L3T4-positive T cells participate in the induction of graft-vs.-host disease in response to minor histocompatibility antigens. J Immunol 1987; 139: 2511.
46. Miconnet I, Huchet R, Bonardelle D, et al. Graft-versus-host mortality induced by noncytolytic CD4+ T cell clones specific for non-H-2 antigens. J Immunol 1990; 145: 2123.
47. Sprent J, Schaefer M, Korngold R. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD. J Immunol 1990; 144: 2946.
48. Murphy GF, Whitaker D, Sprent J, Korngold R. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells. Am J Pathol 1991; 138: 983.
49. Korngold R. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses. Bone Marrow Transplant 1992; 9: 355.
50. Blue ML, Daley JF, Levine H, Schlossman SF. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 1985; 134: 2281.
51. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Bio synthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol 1986; 137: 1202.
52. Sviland L, Pearson AD, Green MA, et al. Expression of MHC class I and class II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Bone Marrow Transplant 1989; 4: 233.
53. Guyotat D, Mauduit G, Chouvet B, et al. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation 1986; 41: 340.
54. Lever R, Turbitt M, Mackie R, et al. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants. Br J Dermatol 1986; 114: 161.
55. Dreno B, Milpied N, Harousseau JL, et al. Cutaneous immuno logical studies in diagnosis of acute graft-versus-host disease. Br J Dermatol 1986; 114: 7.
56. Suitters AJ, Lampert LA. The loss of IA+ Langerhans' cells during graft-versus-host disease in rats. Transplantation 1983; 36: 540.
57. Sloane JP, Dilly SA. Pathogenesis of graft versus host disease. Histopathology 1988; 12: 105.
58. Dickinson AM, Sviland L, Hamilton PJ, et al. Cytokine involve ment in predicting clinical graft-versus-host disease in allogeneic bone marrow transplants recipients. Transplantation 1994; 13: 65.
59. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB. Recombi nant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol 1984; 83: 88.
60. Symington FW, Santos EB. Lysis of human keratinocytes by allogeneic HLA-class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CDlla/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes. J Immunol 1991; 146: 2169.
61. Niederwieser D, Grassegger A, Aubock J, et al. Correlation of minor histocompatibility antigen specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 1993; 81: 2200.
62. Paliard X, de Waal Malefijt R, Yssel H, et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol 1988; 141: 849.
63. Denkers EY, Badger CC, Ledbetter JA, Bernstein ID. Influence of antibody isotype on passive serotherapy of lymphoma. J Immunol 1985; 135: 2183.
64. Sandmaier BM, Schuening FG, Bianco JA, et al. Biochemical characterization of a unique canine myeloid antigen. Leukemia 1991; 5: 125.